Acumen Pharmaceuticals, Inc. (ABOS)
| Previous close | 3.1800 |
| Open | 3.1600 |
| Bid | 3.1100 x 200 |
| Ask | 3.2600 x 100 |
| Day's range | 3.1500 - 3.1800 |
| 52-week range | 1.8100 - 11.3100 |
| Volume | |
| Avg. volume | 337,054 |
| Market cap | 191.054M |
| Beta (5Y monthly) | 0.08 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.0800 |
| Earnings date | 06 May 2024 - 10 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 12.80 |
Insider Monkey12 Cheap Foods With Anti-Aging Properties That Longevity Scientists Swear By
In this article, we will be taking a look at the 12 cheap foods with anti-aging properties that longevity scientists swear by. If you do not want to learn about the anti-aging trends, head straight to 5 Cheap Foods With Anti-Aging Properties That Longevity Scientists Swear By. Anti-Aging Trends: Market Insights & Emerging Solutions Anti-aging […]
GlobeNewswireAcumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting
Presentation and poster include deeper data insights on sabirnetug safety profile, target engagement and fluid biomarker changesPresentation to be featured during AAN Emerging Science SessionCompany on track to initiate Phase 2 trial evaluating sabirnetug in first half of 2024 CHARLOTTESVILLE, Va., April 16, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligom
Insider Monkey13 Best Penny Stocks to Buy According to Billionaire Ken Griffin
In this article, we will take a look at the 13 best penny stocks to buy according to billionaire Ken Griffin. To see more such companies, go directly to 5 Best Penny Stocks to Buy According to Billionaire Ken Griffin. The markets were off to an impressive start in 2024, driven by expectations that the […]
